{"id":"NCT03506815","sponsor":"Ottawa Hospital Research Institute","briefTitle":"Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines","officialTitle":"A Pilot Study Assessing the Feasibility of a Randomized Controlled Trial Investigating Primary Thromboprophylaxis With Rivaroxaban in Patients With Malignancy and Central Venous Catheters","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-15","primaryCompletion":"2020-05-14","completion":"2020-06-14","firstPosted":"2018-04-24","resultsPosted":"2024-07-05","lastUpdate":"2024-07-05"},"enrollment":105,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Upper Extremity Deep Vein Thrombosis","Central Venous Catheter Thrombosis","Cancer"],"interventions":[{"type":"DRUG","name":"Rivaroxaban 10 MG","otherNames":["Xarelto 10mg tablet po daily"]}],"arms":[{"label":"Rivaroxaban Thromboprophylaxis","type":"EXPERIMENTAL"},{"label":"Standard of care","type":"NO_INTERVENTION"}],"summary":"Purpose of the Pilot Trial:\n\nTo determine the feasibility of conducting a multicentre randomized open label controlled trial evaluating the use of prophylactic dose rivaroxaban to prevent central venous catheter (CVC) associated venous thromboembolism (VTE) among cancer patients.\n\nHypothesis: treatment with low dose rivaroxaban (10mg) will reduce the incidence of upper extremity venous thrombosis in a high risk population with cancer and CVC.","primaryOutcome":{"measure":"Primary Feasibility Outcome - Number of Participants Recruited Per Month","timeFrame":"12 months","effectByArm":[{"arm":"Site 1","deltaMin":7.5,"sd":null},{"arm":"Site 2","deltaMin":2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Canada"]},"refs":{"pmids":["34027291"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":52},"commonTop":["Thrombocytopenia","Fever","Rash","Anemia","Chemotherapy Infusion Reaction"]}}